If a Martian landed on Earth, took a read of Biota's investor page (http://investors.biotapharma.com) and decided to take the plunge on the basis of the information provided, one would imagine he'd have a case against the company...
...i guess however that there is no chance of a Martian being so stupid.
So I guess the plan, as they have notified, is to publish Phase 2 results and even with a low PFS proportion and therefore, lower chance of marked statistical difference between LANI and Placebo, hope the FDA approves.
Then we have LANI and Vapendavir (for acute Respiratory) Phase 3 ready. Would any big pharma relieve us of our misery at that point, or will our management superstars have a final Ace card to gamble with?
BTA Price at posting:
0.0¢ Sentiment: Hold Disclosure: Held
